STOCK TITAN
  1. Home
  2. NRNVF

NORDIC NANOVECTO Stock Price, News & Analysis

NRNVF OTC

Company Description

NORDIC NANOVECTO (OTC: NRNVF) is a publicly traded pharmaceuticals: other company in the Health Technology sector.

This page provides a comprehensive overview of NRNVF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
—

Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

clinical trial
—

Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors

management
—

Nordic Nanovector ASA: Results for the First Quarter 2021

earnings
—

Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma

clinical trial
—

Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast

earnings
—

Nordic Nanovector ASA publishes 2020 Annual Report

NORDIC NANOVECTO has 8 recent news articles. Key topics include clinical trial, management, earnings. View all NRNVF news →

SEC Filings

View All

No SEC filings available for NRNVF.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

NRNVF Company Profile & Sector Positioning

NORDIC NANOVECTO (NRNVF) operates in the Pharmaceuticals: Other industry within the broader Health Technology sector and is listed on the OTC.